NCT02379377View on ClinicalTrials.gov

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

PHASE1RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Adult Hepatocellular CarcinomaResectable Hepatocellular CarcinomaCholangiocarcinomaBenign Liver TumorMetastases to Liver
Interventions
BIOLOGICAL

Fluorine F 18 L-glutamate Derivative 18F-FSPG

Undergo 18F-FSPG PET scan

BIOLOGICAL

Carbon C 11 Acetate

Undergo 11C-acetate PET scan

PROCEDURE

Positron Emission Tomography

Undergo 18F-FSPG, 11C-acetate, or 18F-FDG PET

OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Fluorine F 18 2-deoxy-2-(18F)fluoro-D-glucose

Undergo 18F-FDG PET scan

Trial Locations (1)

77090

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER